Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

DHS Seeks BioWatch Sample Laboratory Information Management System

by Global Biodefense Staff
December 12, 2018
Biowatch Laboratory Response Network

The Department of Homeland Security Office of Procurement Operations is conducting market research on technologies that can provide a comprehensive, cost effective solution to BioWatch’s current laboratory information management system.

This desired sample tracking platform will provide the capability to support the laboratories in the BioWatch network to track individual samples, track the reagents associated with the analysis of the sample, trace the data obtained, input this information into a comprehensive database, and report results in a verifiable manner.

The BioWatch Sample Laboratory Information Management System (BW-SLIMS) must be able to accept direct and mediated data from other sample and laboratory information management systems and also be able to send data to such systems. The ultimate goal of the BW-SLIMS is to collect, compile, transmit, and allow queries of sample information from throughout the BioWatch user community.

A laboratory sample information management system will record sample handling activities, promote data entry time efficiencies, minimize data entry errors and strengthen traceability, thus improving BioWatch capabilities and results confidence.

A successful candidate system will:

  • Be fully compatible with multiple, modern computing devices, from smart phones to tablets to traditional laptop and desktop computers
  • Be implementable at numerous facilities across the country with differing IT systems requirements, policies and restrictions
  • Preferably run on widely used commercial off the shelf hardware and software
  • Ensure ability to implement upgrades to commercial systems/platforms (i.e., computers and operating systems)
  • Have compatibility (including backwards) with predecessor and other program data information management systems
  • Be able to withstand normal laboratory decontamination procedures with solutions such as bleach and alcohol when used in Biosafety Level 2 (BSL)-2, BSL-3 laboratories
  • Establish and maintain traceability on the sample from time of accession to completion of analysis, data reporting, archival, and eventual disposition
  • Allow for secondary review and ability to update/modify the records (including person, date, and time stamps) at any point to ensure results confidence and technical defensibility; the system must also be able to document/record supervisory and/or secondary data reviews and any modifications/updates made to the record
  • Be accredited to run on government information systems per Federal Information Security Management Act (FISMA), be government agency whitelist preferred, or have the ability to obtain said accreditation

Responses to this RFI will assist DHS in understanding the number and nature of available solutions. Current demonstrated ability to meet all desired capabilities is not necessary. The submission deadline is Dec 21, 2018 2:00 pm Eastern.

Tags: BioWatchHomeland SecurityRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC